1. Introduction
===============

*Acanthopanax senticosus* (Rupr. Maxim) Harms (Araliaceae) is a well-known Traditional Chinese Medicine in China, which has been officially listed in the Chinese Pharmacopoeia for a long time \[[@B1-molecules-17-07903],[@B2-molecules-17-07903]\]. It possesses various pharmacological effects, such as antibacterial, antifatigue, anti-oxidant and anti-tumor activities \[[@B3-molecules-17-07903],[@B4-molecules-17-07903],[@B5-molecules-17-07903]\]. Recently, Acanthopanax extract was also recorded in the 2010 edition of the Chinese Pharmacopoeia as a new drug \[[@B2-molecules-17-07903]\]. It has also been shown that Acanthopanax extracts can be used as tonics and sedatives for nourishing the liver and kidneys, and strengthening the bones and muscle \[[@B6-molecules-17-07903]\]. *A.senticosus* or its extract have been shown to contain many effective constituents, including syringin, caffeic acid, chlorogenid acid, eleutheroside E and isofraxidin, *etc.* \[[@B7-molecules-17-07903]\]. Syringin and eleutheroside E were considered to possess significant anti-inflammatory effects \[[@B8-molecules-17-07903]\]. Syringin was also proven to be active in protecting against neuritic atrophy and cell death under Abeta treatment \[[@B9-molecules-17-07903]\]. Isofraxidin has demonstrated antifatigue, antistress and immune-accomondating effects \[[@B10-molecules-17-07903]\]. Caffeic acid and chlorogenic acid are the main active lignans of *A.senticosus*, which has obvious anti-oxidant activities \[[@B11-molecules-17-07903]\]. Therefore, the quality control of *A.senticosus* or its extract should be focused on the determination of multiple active compounds. It is not reasonable to adopt a single active constituent to evaluate the quality of *A.senticosus* as one or two constituents could not be responsible for the overall pharmacological activities of *A.senticosus* or its extract. However, only syringin was selected as quantitative constituent for *A.senticosus* in the 2010 edition of the Chinese Pharmacopoeia. At least the five active compounds mentioned above should be measured simultaneously as the marker constituents for quality control of *A.senticosus* and its extracts.

In the present study, a simple, reliable and new ultra performance liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry method (UPLC-TOF-MS) was developed and validated for the simultaneous determination of these five major bioactive constituents in *A. senticosus* and its extracts and successfully applied for the assessment of fifteen commercial samples. The structures of compounds **1**--**5** can be seen in [Figure 1](#molecules-17-07903-f001){ref-type="fig"}. According to the literature, this study represents the first investigation of the simultaneous analysis of multiple components in *A. senticosus* and its extract by UPLC-TOF-MS.

![Structures of syringing (**1**), chlorogenic acid (**2**), caffeic acid (**3**), eleutheroside E (**4**) and isofraxidin (**5**).](molecules-17-07903-g001){#molecules-17-07903-f001}

2. Results and Discussion
=========================

2.1. Optimization of the Chromatographic Conditions
---------------------------------------------------

The selection of mobile phase was a key factor in achieving good chromatographic behavior and appropriate ionization. The resolution of UPLC was tested using both the standard solution and sample solutions. The effect of different mobile phase compositions on chromatographic separation was compared. Acetonitrile-water gave better resolution and peak shapes than methanol-water. Several mobile phase additives, such as formic acid, acetic acid and ammonium acetate were used to achieve better resolution of the analytes. It was found that the good signal intensity, resolution and peak shape were achieved when formic acid was added to both acetonitrile and aqueous solution. But with the increasing added amount of formic acid, the signal intensity showed a downward trend. Ultimately, 0.1% formic acid added to the mobile phase was suitable.

The five components were analyzed by MS in ESI negative ion mode. It can be seen from [Figure 2](#molecules-17-07903-f002){ref-type="fig"} that all targeted compounds syringin (**1**), chlorogenic acid (**2**), caffeic acid (**3**), eleutheroside E (**4**) and isofraxidin (**5**) were baseline separated within 5.3 min in standards and samples, which represented an approximate six-fold reduction in the analysis time in comparison to published HPLC method \[[@B7-molecules-17-07903]\]. Quantitation was carried out working in the V mode using the narrow widow extracted ion chromatograms (nwXICs) of each compound (extracted using a 20 mDa window) ([Figure 3](#molecules-17-07903-f003){ref-type="fig"}A--E). In ESI negative ion of V mode, \[M+HCOO\]^−^ (417.1378, 399.0949 and 787.2695) for compounds **1**, **2** and **4** and \[M−H\]^−^ (179.0334 and 221.0482) for compounds **3** and **5** were considered to have better stability and higher abundance ([Figure 3](#molecules-17-07903-f003){ref-type="fig"}A\'--E\'). Therefore, the narrow widow extracted ions 417.1378, 399.0949, 179.0334, 787.2695 and 221.0482 were chosen for quantitation for compounds **1**--**5**. The analytes were identified by comparing their retention times and accurate *m/z* data with standard solutions containing the corresponding compounds. The typical chromatograms for the standard mixtures analyzed using the optimum chromatographic condition are shown in [Figure 2](#molecules-17-07903-f002){ref-type="fig"}A.

![Total ion chromatogram in negative ion mode of standard (**A**) and sample solutions (**B**); **1**: syringing; **2**: chlorogenic acid; **3**: caffeic acid; **4**: eleutheroside E; **5**: isofraxidin.](molecules-17-07903-g002){#molecules-17-07903-f002}

![Representative nwXIC chromatograms of standard solutions (A--E) and corresponding mass spectrum (A\'--E\'). A and A\', syringing; B and B\', chlorogenic acid; C and C\', caffeic acid; D and D\', eleutheroside E; E and E\', isofraxidin.](molecules-17-07903-g003){#molecules-17-07903-f003}

2.2. Calibration curves, Limits of Detection and Quantification
---------------------------------------------------------------

Stock solutions were diluted to appropriate concentrations in order to plot calibration curves and calculate relative response factors. The calibration curve of the individual standards was constructed using six concentrations (*n*= 3), by plotting peak areas against the concentration of analytes. The calculated results are shown in [Table 1](#molecules-17-07903-t001){ref-type="table"}. Good linearity (*r*\> 0.999) was observed in calibration curves over the concentration ranges investigated. Limits of detection of six compounds varied from 0.008 μg/mL to 0.20 μg/mL, and limits of quantification ranged from 0.03 to 0.60 μg/mL. The results are summarized in [Table 1](#molecules-17-07903-t001){ref-type="table"}.

molecules-17-07903-t001_Table 1

###### 

Calibration parameters of UPLC-MS analysis for the 5 compounds. (**1**: syringin; **2**: chlorogenic acid; **3**: caffeic acid; **4**: eleutheroside E; **5**: isofraxidin).

  No.   Regression equation   Linear range (μg/mL)   r        LODs (μg/mL)   LOQs (μg/mL)
  ----- --------------------- ---------------------- -------- -------------- --------------
  1     y = 24.49x + 91.44    0.2--1000              0.9994   0.008          0.03
  2     y = 14.70x + 75.46    0.2--1000              0.9992   0.02           0.06
  3     y = 14.86x + 78.13    1.0--1000              0.9991   0.04           0.12
  4     y = 11.15x + 49.04    0.2--1000              0.9994   0.008          0.03
  5     y = 5.49x + 29.14     1.0--1000              0.9991   0.20           0.60

2.3. Method Validation
----------------------

Method precision was checked by intra-day and inter-day variability. The samples (A) were prepared as described in the Experimental part. For the intra-day variability test, the samples were analyzed in six replicates once a day, while for the inter-day variability test, the samples were examined for three consecutive days. The RSD was taken as a measure of precision. From the results obtained, the present method was found to show acceptable precision and accuracy, with intra-day variability RSD values between 0.92% and 3.47% and the inter-day variability RSD values between 1.43% and 3.88%.

A recovery study was performed to validate the accuracy of the developed method. Sample 9 of Acanthopanax extract (0.2 g) was spiked with different concentration levels (50, 100 and 150%) of known amounts of the compounds **1**--**5**. The spiked samples were extracted with 10 mL methanol following the procedure for sample preparation as described above. The recovery was determined by comparing the amount of analyte added to the sample and the amount of analyte detected during UPLC-TOF-MS analysis. The recoveries ([Table 2](#molecules-17-07903-t002){ref-type="table"}) of the five analytes were in the range of 96.30--103.70%, with RSDs less than 2.89%. The accuracy of the proposed method was therefore found to be sufficient for the determination of the five compounds in samples from *A. senticosus* and its extract.
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###### 

Recovery experiment of analytical method for five components. (**1**: syringin; **2**: chlorogenid acid; **3**: caffeic acid; **4**: eleutheroside E; **5**: isofraxidin).

  No.   Original (mg)   Spiked (mg)   Found (mg)   Mean recovery (%)   RSD (%) (n = 3)
  ----- --------------- ------------- ------------ ------------------- -----------------
  1     1.022           0.533         1.545        98.13               1.52
                        1.066         2.103        101.41              1.78
                        1.599         2.563        96.37               2.06
  2     0.638           0.262         0.899        99.62               1.05
                        0.524         1.176        102.67              2.14
                        0.786         1.405        97.58               1.25
  3     0.044           0.033         0.078        103.03              0.96
                        0.066         0.109        98.48               1.49
                        0.099         0.145        102.02              2.82
  4     1.172           0.608         1.773        98.85               1.76
                        1.216         2.380        99.34               1.03
                        1.824         2.994        99.89               2.89
  5     0.050           0.027         0.076        96.30               0.89
                        0.054         0.106        103.70              1.81
                        0.081         0.131        98.77               1.67

2.4. Matrix Effects
-------------------

Evaluation of the matrix effects on the results of quantitative determination of multiple components in TCMs is an important and often overlooked element. Matrix effects occur when matrix compounds co-eluting with the analytes alter the ionization efficiency of the electrospray interface. Post extraction addition is an effective method for providing favorable results, even with variable matrices. The sample of *A. senticosus* was extracted as described. Next, 5 mL of the extract was spiked with a one- fold mixed standard solution at three concentration levels (50%, 100% and 150%), and another 5 mL of the extract was diluted one-fold with methanol. Triplicate samples were prepared at each level. The matrix effect was calculated by the formula: matrix effect (%) = (a − b)/c × 100%, where a is the peak area of the analyte in the spiked sample matrix, b is the peak area of the analyte in the unspiked sample matrix and c is the peak area of the standard solution at the same concentration. No matrix effect is observed when the matrix effect (%) is equal to 100%. In this study, the matrix effects of the eight compounds were in the range of 98.6--101.3%, indicating that no matrix effect was observed.

2.5. Sample Analysis
--------------------

The optimum conditions were applied to the determination of compounds **1**--**5** in *A. senticosus* and its extract from different sources. The typical chromatograms obtained are shown in [Figure 2](#molecules-17-07903-f002){ref-type="fig"}B. The quantitative analyses were performed by means of the external standard methods. The contents of the five compounds in *A. senticosus* and its extract from different sources are listed in [Table 3](#molecules-17-07903-t003){ref-type="table"}. The quantitative analytical results indicated that their contents showed great variations. The contents of compound **1** ranged from 0.855 mg/g to 13.551 mg/g in samples 1--12 corresponding to Acanthopanax extract and from 0.067 mg/g to 0.58 mg/g in samples 13--15 corresponding to *A. senticosus* raw materials. Similarly, the contents of compounds **2**, **4** and **5** in Acanthopanax extract ranged from 2.035 mg/g, 1.453 mg/g and 0.103 mg/g to 17.638 mg/g, 23.617 mg/g and 1.967 mg/g, respectively. Compound **3** was absent or not detected in samples 1--7, 10, 12 and 13. Although the differences of the content between the samples from different sources were obvious, it is difficult to distinguish the sources of the samples. Generally, the variations were based on internal factors such as genetic variation and plant origin as well as external factors including seasonal, environmental factors, harvest time, and storage conditions and extract process. To ensure the quality of Acanthopanax extract, this suggests that each procedure involved should be standardized.
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###### 

The measurement results of compounds **1**--**5** in *A. senticosus* and its extract (mg/g).

  No.   1 (syringin)   2 (chlorogenic acid)   3 (caffeic acid)   4 (eleutheroside E)   5 (isofraxidin)
  ----- -------------- ---------------------- ------------------ --------------------- -----------------
  1     12.857         10.131                 Trace              21.004                1.150
  2     11.326         11.844                 Trace              14.530                1.446
  3     13.551         12.146                 Trace              16.208                1.586
  4     4.364          12.057                 Trace              13.853                0.841
  5     4.919          13.721                 Trace              15.582                1.036
  6     9.235          17.638                 Trace              23.617                1.967
  7     0.906          3.508                  Trace              10.108                1.967
  8     5.242          4.708                  0.308              6.273                 0.225
  9     5.109          3.191                  0.219              5.861                 0.248
  10    0.855          2.039                  Trace              1.453                 0.103
  11    5.492          2.035                  0.262              6.350                 0.270
  12    0.894          2.637                  Trace              1.603                 0.107
  13    0.067          0.369                  Trace              0.424                 Trace
  14    0.580          1.240                  0.041              0.620                 0.019
  15    0.285          0.648                  0.035              0.192                 0.026

2.6. Quality Assessment of *A. senticosus* Samples by Principal Component Analysis
----------------------------------------------------------------------------------

The data of these five analytes were used to carry out principal component analysis (PCA). The 5 × 15 auto-scaled data matrix was then submitted to PCA analysis by an SPSS version 16.0 statistical analysis package (SPSS Inc., Chicago, IL, USA). A two-component score plot of UPLC data was utilized to depict general variations of samples among the different sources. The clear separation of different *A. senticosus* and its extract samples was observed in the PCA score plot, where each coordinate represents a sample. The examination of the score plot demonstrated that PCA of UPLC data obtained from 15 samples divided the samples into three groups ([Figure 4](#molecules-17-07903-f004){ref-type="fig"}A).

![(**A**) Score plots from PCA; (**B**) loading plots from PCA.](molecules-17-07903-g004){#molecules-17-07903-f004}

Samples 8, 9 and 11 from the factory of Wusulijiang were attributed to group A, which represents raw materials from Shangzhi of Heilongjiang. The samples 1--7 for group B were from two factories of Wusulijiang and Renhuang, which represent raw materials from Wuchang of Heilongjiang. The samples 10 and 12 from the factory of Wusulijiang were similar to raw material samples 13--15, which were attributed to group C. The difference between these *A. senticosus* samples is a result of them coming from different manufacturers, plant origins, harvest time and extract processes. The loading plot was utilized to identify the differential analytes accountable for the separation among different groups ([Figure 4](#molecules-17-07903-f004){ref-type="fig"}B). For example, all targeted compounds showed negative association with group B, which are also in accordance with the fact that the contents of syringin, chlorogenic acid, caffeic acid, eleutheroside E and isofraxidin are much lower in samples 10 and 12--15 than other samples.

3. Experimental
===============

3.1. Chemicals and Reagents
---------------------------

Chromatography grade acetonitrile was purchased from Merck (Darmstadt, Germany). Deionized water was purified by Milli-Q system (Millipore, Bedford, MA, USA). Detailed information of *A. senticosus* and its extract can be seen in [Table 4](#molecules-17-07903-t004){ref-type="table"}. Standards of syringin (**1**), chlorogenic acid (**2**), caffeic acid (**3**), eleutheroside E (**4**) and isofraxidin (**5**) were all ordered from the Chinese National Institute of Control of Pharmaceutical and Biological Products (Beijing, China). Their structures can be seen in [Figure 1](#molecules-17-07903-f001){ref-type="fig"}. All other reagents were of analytical grade.
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###### 

Detailed information of *A. senticosus* samples.

  Samples   Plant origins            Collection time   Factories     Properties
  --------- ------------------------ ----------------- ------------- -------------------
  1--3      Wuchang, Heilongjiang    March 2011        Renhuang      Extract
  4--7      Wuchang, Heilongjiang    January 2011      Wusulijiang   Extract
  8--9      Shangzhi, Heilongjiang   December 2010     Wusulijiang   Extract
  10        Harbin, Heilongjiang     April 2011        Wusulijiang   Extract
  11        Shangzhi, Heilongjiang   March 2011        Wusulijiang   eExtract
  12        Harbin, Heilongjiang     May 2011          Wusulijiang   Extract
  13        Shangzhi, Heilongjiang   November 2010     \-            Medical materials
  14        Wuchang, Heilongjiang    September 2010    \-            Medical materials
  15        Anhui                    February 2011     \-            Medical materials

3.2. Sample Preparation of Acanthopanax Extract
-----------------------------------------------

The 12 batches of Acanthopanax extract were prepared for each pharmaceutical factory by the same method recorded in Chinese Pharmacopoeia 2010. Namely, 1,000 g of *A. senticosus*were ground to a suitable particle size and boiled in water for 3 h each time (×2) and the combined solution was filtered and concentrated under vacuum and the concentrate were finally prepared by spray drying.

3.3. Analytical Sample Preparation
----------------------------------

The dried powders of Acanthopanax extract (1.0 g) were accurately weighed and dissolved in a 25 mL volumetric flask with methanol. The methanol solution was filtered through a 0.22 μm filter membrane for UPLC injection. The dried powders of *A.senticosus* (1.0 g, 60 mesh) were accurately weighed and extracted with ultrasonic assistance with 10 mL of methanol solution for 30 min. Then the resultant mixture was adjusted to the original weight and the supernatant were filtered through a 0.22 μm membrane before UPLC injection.

3.4. UPLC-MS Conditions
-----------------------

The UPLC-MS analysis was performed on a Waters ACQUITY UPLC system (Waters Corporation, Milford, PA, USA) coupled with a Waters LCT Premier XE equipped with electrospray ionization. For the reversed-phase UPLC analysis, the ACQUITY UPLC^TM^ HSS C18 column (100 mm × 2.1 mm i.d., 1.7 μm, Waters Corporation) was used. The column temperature and sample temperature were maintained at 40 °C and 4 °C, respectively; the flow rate of the mobile phase was 0.40 mL/min; the injection volume was fixed at 1.0 μL. Mobile phase A consisted of 0.1% formic acid in acetonitrile, while mobile phase B consisted of 0.1% formic acid in water. The column was eluted with a linear gradient of 12--13.5% A over initial to 2.0 min, 13.5--45% A over 2.0--7.0 min, 45--65% A over 7.0--8.0 min, 65--100% A over 8.0--9.0 min.

The mass spectrometric full-scan data were acquired in the negative ion by V mode from 100 to 1,500 Da with a 0.1 s scan time. Other conditions were as follows: capillary voltage of 1.8 kV, desolvation temperature of 350 °C, sample cone voltage of 60 V, extraction cone voltage of 4.0 V, source temperature of 110 °C, cone gas flow of 20 L/h and desolvation gas flow of 750 L/h for negative ion mode. Data were centroided and mass was corrected during acquisition using an external reference (Lock-Spray^TM^) consisting of a 0.2 ng/mL solution of leucine enkephalin infused at a flow rate of 50 μL·min^−1^ via a lockspray interface, generating a reference ion for negative ion mode (\[M−H\]^−^ = 554.2615) to ensure accuracy during the MS analysis.

3.5. Standard Preparation and Calibration Curves
------------------------------------------------

A methanol stock solution containing all five reference standards was prepared by dissolving the reference standards in methanol to final concentration of 1,000 μg/mL for each reference standard, then diluted the mixture stock solution to an appropriate concentration to establish calibration curves. Each calibration curve concentration was done in triplicate. All calibration curves were constructed from peak areas of reference standards *versus* their concentrations. The lowest concentration of working solution was diluted with methanol to yield a series of appropriate concentrations, and the LOD and LOQ under the chromatographic conditions were separately determined at an S/N of 3 and 10, respectively. The results are summarized in [Table 1](#molecules-17-07903-t001){ref-type="table"}.

4. Conclusions
==============

A new UPLC-TOF-MS method has been developed for the first time for the simultaneous determination of five major active constituents in Acanthopanax extract and raw materials. The validation data indicated that this method is reliable and can be applied to determine the contents of these five compounds in Acanthopanax extract and raw materials from different sources. This valuable information concerning the concentration of these pharmacologically active constituents in Acanthopanax extract and raw materials could be of great importance for the quality assessment and should therefore be useful for the guidance of clinical use. This new assay also meets the need for simultaneous determination of multiple constituents in Acanthopanax extract and raw materials by UPLC-TOF-MS, which reduced the sample handling and analytical time by six-fold, and the detection limit by five- to 1,000-fold, compared to published methods \[[@B7-molecules-17-07903]\].
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